Endeavor Resolute DES

Related by string. * Endeavoring . endeavored . endeavoring . ENDEAVOR . Endeavors : Endeavor stent . Morris Endeavor . Providers endeavor . artistic endeavors . Mitsubishi Endeavor / RESOLUTE . resolute : Resolute drug eluting . take resolute countermeasures . storied Resolute desk . resolute countermeasures . Resolute Nunavut / deer . deed . Deer . Des : de la Vega . de l' . Prix de l' . Deer Valley * *

Related by context. Frequent words. (Click for all words.) 60 TYKERB 59 active comparator 59 ACTEMRA 59 multicenter clinical 57 multicenter study 57 multicentre 57 STELARA 57 randomized Phase III 56 Taxotere ® 55 blinded placebo controlled 55 dabigatran etexilate 55 PROMACTA 55 XGEVA 54 certolizumab pegol 54 JANUVIA 54 substudy 54 plus prednisone 54 CYPHER ® Stent 54 retrospective cohort study 54 bivalirudin 54 COPAXONE R 54 SPIRIT III 53 adalimumab 53 PEG INTRON 53 SEROQUEL 53 Phase III randomized 53 RESOLUTE 53 tocilizumab 53 multicenter randomized 53 lacosamide 53 multicenter randomized double 53 peg IFN 53 Myocardial Infarction 53 diabetic neuropathic pain 53 CYPHER R Stent 53 composite endpoint 53 multicenter 53 decitabine 52 hepatocellular carcinoma HCC 52 vandetanib 52 PegIntron 52 stable angina 52 phase IIa 52 hepatitis C HCV 52 Phenoptin 52 TAXUS stent 52 EORTC 52 ticagrelor 51 Phase 1b clinical 51 placebo controlled randomized 51 dacarbazine 51 Amigal 51 abatacept 51 Phase IIa trial 51 randomized controlled 51 tgAAC# 51 label dose escalation 51 plus methotrexate 51 HCV infected 51 hepatocellular carcinoma 51 randomized controlled clinical 51 randomized 51 chronic HCV infection 51 FOSRENOL R 50 blind placebo controlled 50 Phase 2a trial 50 Phase 2b study 50 peginterferon 50 Chronic Hepatitis C 50 ISENTRESS 50 bronchial thermoplasty 50 PEGINTRON 50 CMV infection 50 dose escalation study 50 chemoradiation 50 FOLFOX 50 metastatic renal cell carcinoma 50 vinorelbine 50 peginterferon alfa 2a 50 6R BH4 50 etanercept 50 sustained virologic response 50 adefovir 50 phase IIb 50 peginterferon alfa 2b 49 temsirolimus 49 pazopanib 49 tamsulosin 49 RG# [001] 49 lubiprostone 49 prospective cohort 49 randomized clinical 49 Phase III pivotal 49 Phase 2b clinical 49 Phase Ib 49 noninferiority 49 sunitinib 49 Monotherapy 49 plus ribavirin 49 sitagliptin 49 eculizumab

Back to home page